Larimar Therapeutics (LRMR) Interest & Investment Income (2016 - 2020)
Historic Interest & Investment Income for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to $258000.0.
- Larimar Therapeutics' Interest & Investment Income fell 5981.31% to $258000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $1.6 million, marking a year-over-year decrease of 2910.78%. This contributed to the annual value of $2.0 million for FY2019, which is 529.38% up from last year.
- Per Larimar Therapeutics' latest filing, its Interest & Investment Income stood at $258000.0 for Q1 2020, which was down 5981.31% from $335000.0 recorded in Q4 2019.
- In the past 5 years, Larimar Therapeutics' Interest & Investment Income registered a high of $675000.0 during Q4 2018, and its lowest value of $209000.0 during Q1 2016.
- Its 5-year average for Interest & Investment Income is $354470.6, with a median of $266000.0 in 2017.
- Per our database at Business Quant, Larimar Therapeutics' Interest & Investment Income surged by 43589.74% in 2016 and then tumbled by 5981.31% in 2020.
- Larimar Therapeutics' Interest & Investment Income (Quarter) stood at $230000.0 in 2016, then increased by 11.3% to $256000.0 in 2017, then skyrocketed by 163.67% to $675000.0 in 2018, then crashed by 50.37% to $335000.0 in 2019, then dropped by 22.99% to $258000.0 in 2020.
- Its last three reported values are $258000.0 in Q1 2020, $335000.0 for Q4 2019, and $451000.0 during Q3 2019.